Immunomic Therapeutics Company
Immunomic Therapeutics is a development stage biotechnology company that develops lysosomal associated membrane protein-based vaccines.
Investors
Technology:
Dendritic Cells, DNA, RNA
Industry:
Dendritic Cells, DNA, RNA
Headquarters:
Lancaster, Pennsylvania, United States
Founded Date:
2005-01-01
Employees Number:
11-50
Investors Number:
6
Total Funding:
445000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2020-04-23
Last Funding Type:
Corporate Round
Register and Claim Ownership